1 / 1

# Antibody-Functionalized Carbon Nanotubes in Cancer Therapy * - PowerPoint PPT Presentation

Antibody-Functionalized Carbon Nanotubes in Cancer Therapy * Kyung Kim**, Kristina Tran**, and Dr. Miguel Bagajewicz University of Oklahoma—Chemical Engineering. * This work was done as part of the Capstone chemical engineering class at the University of Oklahoma

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.

## PowerPoint Slideshow about 'Antibody-Functionalized Carbon Nanotubes in Cancer Therapy *' - cloris

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

Antibody-Functionalized Carbon Nanotubes in Cancer Therapy*

Kyung Kim**, Kristina Tran**, and Dr. Miguel Bagajewicz

University of Oklahoma—Chemical Engineering

* This work was done as part of the Capstone chemical engineering class at the University of Oklahoma

Abstract

Mathematical Modeling for Tumor Targeting

Photothermal Therapy

A mathematical model is used to determine appropriate timing of an existing cancer treatment based on attaching monoclonal antibodies (mAb) to single-walled carbon nanotubes (SWNT) for breast cancer cells. The mathematical model predicts the initial dosage for intravenous injection and near-infrared (NIR) radiation emission intensity and timing as a function of the tumor volume.

Temperature Gradient of the Tumor Cell at

Plasma & Lymph Flow Diagram

Two-pore Model

t = 1 min

t = 2 min

t = 3 min

Introduction

• Monoclonal antibodies are produced by one type of immune cell. They are used to specifically target cancer cells.

• Single-walled carbon nanotubes are graphite sheets rolled into a cylinder. Strong absorption of NIR radiation is one of their unique properties.

• Researchers have recently conjugated mAbs to SWNTs to target breast cancer cells. By using a NIR laser, the localized heating due to the high thermal conductivity of SWNTs led to successful eradication of the cancer cells1.

The two-pore model shows how mAbs travel through the organs and tissues.

It also explains the diffusion of mAbs into the interstitium through the blood vessel wall.

Monoclonal

antibody

Two Subcompartments Model

Immunoglobulin IgG is dispersed to the vascular and interstitial spaces through plasma flow. Their half-life is determined by the FcRn receptor in endothelial cells. This model describes the catabolic process of IgG through its internalization into the organ and tissues.

Conclusions

HER2 receptor

(on breast cancer cells)

Single-walled carbon nanotube

We have successfully modeled

• the initial dosage requirement of the drug as a function of tumor volume

• the required time for NIR emission following injection

• the required time for tumor cell damage

Based on the temperature gradient of the tumor during irradiation, damage to the surrounding normal cells will be minimal. It is not desirable to have the tumor cells reach temperatures above 80°C due to bubbling of the tumor and subsequent damage to surrounding normal cells. Therefore, an irradiation time of three minutes is sufficient for eradication of tumor cells.

Cancer cell

Crossing Barriers

Due to their small size, nanosystems have been shown to overcome biological barriers, such as the blood-brain barrier, which makes them attractive for cancer therapy.

kint : Rate constant of internalization

kcat: Rate constant for lysosomal degradation

krec: Rate constant for recycling of Fc-Rn bound

Cm: Concentration of catabolites

CLorg: Catabolite clearance rate

Jv : Fluid flux

αL, αS : Fraction of bulk fluid

Functionalizing SWNTs with mAbs

Concentration of mAbs in the Body

The functionalization of SWNTs with mAbs serves to deliver SWNTs to the cancer site for phototherapy.

Monoclonal antibody

Acknowledgements

We would like to thank the following for their guidance and help in our project: Chiranth Srinivasan, Dr. Daniel Resasco, Dr. Lance Lobban, Dr. Liang Zhang, Dr. Barbara Safiejko-Mroczka, and Kevin Bagnall.

Surfactant

SWNT

References

.Shao, N., Lu, S., Wickstrom, E., and Panchapakesan, B., Integrated molecular targeting of IGF1T and HER2

surface receptors and destruction of breast cancer cells using single wall carbon nanotubes, Nanotechnology (2007), 18:1-9.

2. Davda, J. P., Jain, M., Batra, S. K., Gwilt, P. R., Robinson, D. H., A physiologically based pharmacokinetic (PBPK) model to characterize and perdict the disposition of monoclonal antibody CC49 and its single chain Fv constructs, International Immunopharmacology (2008) 8:401-413.

3. Meyskens, F., Thomson, S., Moon, T., Quantitation of the Number of Cells within Tumor Colonies in Semisolid Medium and Their Growth as Oblate Spheroids, Cancer Research (1984), 271-277.

4. G. Z. Ferl, A. M. Wu, J. J. Distefano III, A predictive model of therapeutic monoclonal antibody dynamics and regulation by the newnatal Fc Receptor (FcRn), Annals of Biomedical Engineering (2005) 33( 11): 1640-1652.

Sources

Shao, N., Lu, S., et al., Integrated molecular targeting of IGF1T and HER2 surface receptors and destruction of breast cancer cells using single wall carbon nanotubes, Nanotechnology (2007), 18:1-9.

University of Maine, Department of Chemistry, <http://chemistry.umeche.maine.edu/CHY431/Antibody.jpg>